For the safety of our patients and staff, we have updated our visitor policy, effective December 27. This includes important information about COVID-19 vaccination or testing for some visitors. Read the latest information for visitors.
From Bench to Clinic: BTK Inhibitor Fenebrutinib for the Treatment of RA & Lupus
This program is open to the research community.
Date & Time(s)
Memorial Sloan Kettering Cancer Center
Zuckerman Research Center
417 East 68th Street
New York, NY 10065
Sanders Tri-Institutional Chemical Biology Seminar Series
Dr. Michael Foley
Wendy Young, PhD
Small Molecule Discovery Chemistry
San Francisco, CA